A PYMNTS Company

US: Affymetrix rejects $1.5 billion takeover bid

By  |  March 21, 2016

Affymetrix, a maker of advanced genetic analysis technology, on Sunday rejected an 11th-hour takeover bid meant to derail its planned sale to Thermo Fisher Scientific for $1.3 billion.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In a statement, Affymetrix said that the $1.5 billion offer by some of its former employees, who have set up a shell company called Origin Technologies, was not a “superior proposal” to the Thermo Fisher deal.

    The move complicates what has already become a complex situation and suggests that both the target company and its preferred buyer will maintain a robust defense of their transaction ahead of a vote by Affymetrix shareholders on the deal this week.

    Full content: The New York Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.